Company: HURA
Filing Date: 2025-05-06
Form Type: CORRESP
Source: 0001193125-25-113948
Chunk: 1

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: CORRESP
Chunk 1
---
 included in the proxy statement/prospectus. Refer to Item 303(b) of Regulation S-K and Instruction 1 thereto.                                                                                             |

RESPONSE: For the information of the Staff, subsequent to the initial filing of the Registration Statement and the filing of this Amendment, each of TuHURA and Kineta, Inc. (“Kineta”) has filed its respective Annual Report on Form 10-Kfor its fiscal year ended December 31, 2024. Accordingly, the audited annual financial statements as of

U.S. Securities and Exchange Commission

May 6, 2025

Page
2

and for the year ended December 31, 2024 for each of TuHURA and Kineta have been included in this Amendment, and therefore interim financial statements of TuHURA and Kineta are no longer
included in the Registration Statement. Correspondingly, the management discussion and analysis for each of TuHURA and Kineta have been updated to cover the full 2024 and 2023 fiscal years.

* * *

U.S. Securities and Exchange Commission May 6, 2025 Page 3 We thank the Staff for its review of the foregoing and the Registration Statement. Should any member of the Staff of the Commission have any questions or comments with respect to the foregoing, please contact me at (813) 225-4122or via email at ccreely@foley.com.

| Very truly yours,   |
| /s/ Curt P. Creely  |
| Curt P. Creely      |
| Foley & Lardner LLP |

| cc: | James A, Bianco, M.D., TuHURA Biosciences, Inc. |

Craig Philips, Kineta, Inc. Garrett Bishop, Foley & Lardner LLP Albert Vanderlaan, Orrick, Herrington & Sutcliffe LLP